SQUAWK/NEWS
Account
Theme
Account
Menu
Live NewsCategoriesequity

Aurora Cannabis Inc. (ACB) News

Follow Aurora Cannabis Inc. (ACB) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 55 public stories across 15 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol ACB Asset equity Sector Markets 90 days 48 Last 4.16 Updated Nov 05, 2026, 02:33 PM UTC Open live news feed Open ACB chart & news
M Aurora Cannabis Announces Fiscal 2027 Second-Quarter Results EQUITY | Nov 05, 2026, 02:33 PM UTC M Aurora Cannabis Adjusted Net Income Declines Year Over Year Aurora Cannabis reported a year-over-year decline in adjusted net income for fiscal Q2 2027. EARNINGS | Nov 05, 2026, 02:14 PM UTC M Aurora Cannabis Q2 Revenue Beats Estimates on International Demand EQUITY | Nov 05, 2026, 12:48 PM UTC M Aurora Cannabis Reports Q2 Revenue of CA$86.0M Aurora Cannabis reported Q2 revenue of CA$86.0 million, compared with a FactSet estimate of CA$71.4 million. EQUITY | Nov 05, 2026, 12:16 PM UTC M Aurora Cannabis Reports Fiscal 2027 Second-Quarter Results Aurora Cannabis announced results for the quarter ended September 30, 2026. The company also cancelled its scheduled investor call. EQUITY | Nov 05, 2026, 12:05 PM UTC M Curaleaf Says Its Aurora Takeover Bid Still Stands After Rival Deal Curaleaf said its offer to acquire Aurora Cannabis remains outstanding after Aurora accepted Organigram Global’s buyout offer. MNA | Nov 03, 2026, 11:11 PM UTC M Organigram Agrees to Buy Aurora Cannabis for C$560 Million Organigram agreed to acquire Aurora Cannabis for a total of C$560 million. The deal tops Curaleaf’s long-running hostile bid for Aurora. MNA | Nov 03, 2026, 07:16 PM UTC M Transaction Values Aurora at Approximately C$561M The transaction values Aurora at approximately C$561 million on a fully diluted equity value basis. MNA | Nov 03, 2026, 05:21 PM UTC M Organigram Global to Acquire Aurora Cannabis for CA$7.80 per Share EQUITY | Nov 03, 2026, 04:52 PM UTC M Organigram’s C$561 Million Offer Fends Off Curaleaf’s Hostile Aurora Bid Organigram’s roughly C$561 million cash-and-stock offer for Aurora Cannabis at C$7.80 a share is agreed, compared with Curaleaf’s unsolicited C$6.45 bid. The offer represents a 21% premium over Curaleaf’s bid. MNA | Nov 03, 2026, 04:21 PM UTC M Organigram to Acquire Aurora Cannabis in C$561 Million Deal Aurora Cannabis agreed to be acquired by Organigram Global in a deal valued at C$561 million ($401.1 million), fending off a hostile bid from Curaleaf Holdings. EQUITY | Nov 03, 2026, 02:51 PM UTC L Trading Resumes in Aurora Cannabis Trading in Aurora Cannabis (ACB) has resumed on the TSX. EQUITY | Nov 03, 2026, 02:41 PM UTC M Transaction Values Aurora at About C$561M on Fully Diluted Basis MNA | Nov 03, 2026, 02:18 PM UTC M Organigram to Acquire Aurora for C$7.80 per Share Organigram will acquire Aurora for C$7.80 per Aurora common share. EQUITY | Nov 03, 2026, 02:18 PM UTC M CIRO halts trading in ACB CIRO says trading in Aurora Cannabis shares has been halted. EQUITY | Nov 03, 2026, 01:47 PM UTC L ACB: trading halted on Nasdaq — news pending (8:25 AM ET) Nasdaq halted trading in ACB (news pending) at 8:25 AM ET. EQUITY | Nov 03, 2026, 01:25 PM UTC M Alberta Securities Commission Dismisses Curaleaf Application on Aurora ATM Program The Alberta Securities Commission dismissed Curaleaf’s application and ruled in favour of Aurora Cannabis’s at-the-market program. REGULATION | Oct 26, 2026, 12:48 PM UTC M Aurora Urges Shareholders to Reject Curaleaf’s Revised Hostile Bid Aurora Cannabis says its board reconfirmed its recommendation that shareholders reject Curaleaf’s revised hostile bid. MNA | Oct 14, 2026, 07:50 PM UTC M Curaleaf Files Sweetened $324.2M Offer for Aurora Cannabis Curaleaf Holdings has officially filed its increased takeover offer for Aurora Cannabis in a bid to force transaction talks and test whether competing offers will emerge. MNA | Oct 06, 2026, 04:40 PM UTC M Curaleaf Sweetens Aurora Cannabis Offer to $324.2M Curaleaf Holding has sweetened its offer for Aurora Cannabis to $324.2 million, aiming to attract institutional investors and initiate negotiations. EQUITY | Oct 05, 2026, 10:43 PM UTC M Aurora Cannabis Shares Rise on Sweetened Curaleaf Takeover Offer Aurora Cannabis shares surged Monday after Curaleaf Holdings boosted its hostile takeover offer. Under the revised terms, Aurora shareholders would receive... MNA | Oct 05, 2026, 02:41 PM UTC H Curaleaf raises Aurora Cannabis takeover offer to $324.2 million Curaleaf Holdings has increased its hostile takeover offer for Canadian cannabis producer Aurora Cannabis to $324.2 million, or $5.00 a share, in an effort to pressure Aurora's board into negotiations. The new offer incl EQUITY | Oct 05, 2026, 12:43 PM UTC M Curaleaf Increases Cash Consideration to $1 Per Aurora Share Curaleaf has increased its cash consideration by 33% to $1 per Aurora share. MNA | Oct 05, 2026, 12:02 PM UTC L Aurora Cannabis: Intends to Demonstrate Curaleaf's Circular Hasn't Satisfied Several Regulatory Requirements >ACB Aurora Cannabis: Intends to Demonstrate Curaleaf's Circular Hasn't Satisfied Several Regulatory Requirements >ACB NEWS | Sep 23, 2026, 10:30 PM UTC L Aurora Cannabis: Application Filed With Alberta Securities Commission for Order Requiring Curaleaf to Comply With Securities Laws Aurora Cannabis: Application Filed With Alberta Securities Commission for Order Requiring Curaleaf to Comply With Securities Laws NEWS | Sep 23, 2026, 10:30 PM UTC L ACB - Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure ACB - Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure NEWS | Sep 23, 2026, 10:29 PM UTC L Aurora Cannabis Inc. (ACB) Seeks ASC Order on Curaleaf Bid Disclosures Aurora filed an application with the Alberta Securities Commission alleging deficiencies in Curaleaf’s hostile bid circular and seeks corrections and a full 105-day deposit period.Material DetailsContext by AI AnalystThi NEWS | Sep 23, 2026, 10:29 PM UTC L Aurora Cannabis Files Application with Alberta Securities Commission to Protect Company Shareholders Having Identified Several Deficiencies in Curaleaf's Hostile Bid Disclosure NASDAQ | TSX:ACBEDMONTON, AB, Sept. 23, 2026 /CNW/ -- Aurora Cannabis Inc. ("Aurora" or the "Company") (NASDAQ:ACB) (TSX:ACB), the Canadian-based leading global medical cannabis company, today filed an application with t NEWS | Sep 23, 2026, 10:29 PM UTC H Aurora Cannabis Re-Affirms FY27 Q2 Guidance For Sequential Growth In Quarterly Net Revenue And Adjusted EBITDA Re-affirms FY27 Q2 guidance for sequential growth in quarterly net revenue and adjusted EBITDA1 Following the receipt of EU-GMP certification in July, Safari Flower Company is expected to contribute incremental net reven LIVE | Sep 16, 2026, 11:07 AM UTC M Aurora Cannabis reaffirms FY27 Q2 guidance for sequential quarterly revenue Aurora Cannabis re-affirms its FY27 2Q guidance, citing sequential growth in quarterly net revenue. EQUITY | Sep 16, 2026, 11:06 AM UTC L ACB - Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond ACB - Aurora Cannabis Provides Business Update; Accretive Acquisition of Safari Flower Company and Leading European Performance Expected to Fuel International Growth in the Fiscal Second Quarter 2027 and Beyond MNA | Sep 16, 2026, 11:05 AM UTC L ACB appoints biopharmaceutical executive to lead medical cannabis commercial acceleration Aurora Cannabis (ACB) appoints a seasoned biopharmaceutical executive to lead commercial acceleration of its global medical cannabis business. EQUITY | Sep 09, 2026, 11:06 AM UTC L Aurora Cannabis appoints Faris El Refaie to lead global commercial push Aurora Cannabis says biopharmaceutical executive Faris El Refaie, with 25 years of experience, will join as Executive Vice President for Global Commercial operations. EQUITY | Sep 09, 2026, 11:05 AM UTC H Bank of Canada keeps policy rate steady at 2.25% Bank of Canada left its main interest rate unchanged at 2.25% and took a more alarmed tone on upside inflation risks tied to new cross-border tariffs and no imminent end to the war in the Middle East. CENTRAL_BANK | Sep 02, 2026, 08:32 PM UTC M Aurora Cannabis urges shareholders to reject Curaleaf hostile bid Aurora Cannabis urged shareholders to reject Curaleaf Holdings’ unsolicited $272 million hostile takeover offer, saying it is inadequate and undervalues parts of Aurora’s business. MNA | Sep 02, 2026, 04:24 PM UTC L Curaleaf: 'Not Once Has There Been a Counteroffer Presented to Us' Curaleaf: 'Not Once Has There Been a Counteroffer Presented to Us' EQUITY | Sep 02, 2026, 03:20 PM UTC L ACB responds to Aurora circular, reiterates best value path ACB responded to an Aurora circular and reaffirmed its offer as the best path to value creation for shareholders. EQUITY | Sep 02, 2026, 03:18 PM UTC L Curaleaf offer undervalues Aurora medical business, CEO says Curaleaf’s offer is seen as undervaluing Aurora’s medical cannabis business, according to the CEO. EQUITY | Sep 02, 2026, 02:45 PM UTC L Aurora Cannabis open to different offers, CEO says Aurora Cannabis says it remains open to different offers, per its CEO. EQUITY | Sep 02, 2026, 02:45 PM UTC L Aurora Cannabis CEO: 'Medical Cannabis Is Probably the Best Part of the Cannabis Ecosystem' >CURA.T Aurora Cannabis CEO: 'Medical Cannabis Is Probably the Best Part of the Cannabis Ecosystem' >CURA.T EQUITY | Sep 02, 2026, 02:45 PM UTC L Aurora Cannabis CEO says Curaleaf bid undervalues business Aurora Cannabis CEO Miguel Martin said Curaleaf's bid undervalues the business. EQUITY | Sep 02, 2026, 02:45 PM UTC H Aurora Cannabis urges shareholders to reject Curaleaf hostile bid Aurora Cannabis is urging shareholders to reject Curaleaf Holdings’ unsolicited $272 million hostile takeover offer, calling it inadequate and aimed at using Aurora’s clean balance sheet to absorb Curaleaf’s heavy debt l MNA | Sep 02, 2026, 12:41 PM UTC L Aurora Cannabis urges shareholders to reject Curaleaf takeover bid Aurora Cannabis says its board is unanimous in urging shareholders to reject Curaleaf Holdings’ unsolicited takeover bid, calling it an undervaluation of Aurora’s current business and future potential. MNA | Sep 02, 2026, 11:56 AM UTC L Aurora Cannabis says Curaleaf bid undervalues company Aurora Cannabis said Curaleaf’s bid undervalues the company. EQUITY | Sep 02, 2026, 11:08 AM UTC M Aurora Cannabis urges shareholders to reject Curaleaf hostile bid Aurora Cannabis says Curaleaf’s hostile bid is inadequate, undervalues Aurora, and risks shareholder value and future upside. EQUITY | Sep 02, 2026, 11:05 AM UTC L ACB - Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation ACB - Curaleaf Responds to Aurora Cannabis' Latest Attempt to Deflect From Shareholder Value Creation EQUITY | Aug 24, 2026, 07:46 PM UTC L Aurora Cannabis special committee has not yet recommended Curaleaf offer Aurora Cannabis says its special committee of the board has not yet made a formal recommendation regarding the Curaleaf offer. MNA | Aug 24, 2026, 11:10 AM UTC L Aurora Cannabis corrects statements supporting Curaleaf hostile bid Aurora Cannabis says it is correcting inaccurate statements made in support of Curaleaf Holdings' hostile bid. MNA | Aug 24, 2026, 11:06 AM UTC M Aurora Cannabis acquires Internode Pharma and HAP Pharma Aurora Cannabis says it is acquiring Internode Pharma Limited and HAP Pharma Limited to expand distribution access to the UK medical cannabis market. MNA | Aug 19, 2026, 05:46 PM UTC H Aurora Cannabis urges no action on Curaleaf unsolicited bid Aurora Cannabis (ACB) urges shareholders to take no action at this time regarding Curaleaf Holdings’ unsolicited take-over bid. MNA | Aug 19, 2026, 11:06 AM UTC L Trading Halt: Halt status updated at 4:15:00 PM ET: Quotation Resumption: News and Resumption Times Trading Halt: Halt status updated at 4:15:00 PM ET: Quotation Resumption: News and Resumption Times EQUITY | Aug 11, 2026, 08:15 PM UTC L Aurora Cannabis Says Board To Form Special Committee To Review Curaleaf's Unsolicited $4.00 Per Share Take-Over Proposal; Says $5.00 Cap Bel Aurora Cannabis Says Board To Form Special Committee To Review Curaleaf's Unsolicited $4.00 Per Share Take-Over Proposal; Says $5.00 Cap Below December 2025 Trading Levels EQUITY | Aug 11, 2026, 07:28 PM UTC H Aurora Cannabis Responds To Curaleaf Takeover Bid Aurora Cannabis responds to Curaleaf's intention to launch an unsolicited takeover bid MNA | Aug 11, 2026, 07:23 PM UTC L ACB ACB ACB - Aurora Cannabis Announces Fiscal 2027 First Quarter Results ACB ACB ACB - Aurora Cannabis Announces Fiscal 2027 First Quarter Results EARNINGS | Aug 05, 2026, 11:02 AM UTC L ACB Aurora Cannabis Unit Safari Flower Receives EU-GMP Certification at Niagara Facility ACB Aurora Cannabis Unit Safari Flower Receives EU-GMP Certification at Niagara Facility EQUITY | Jul 23, 2026, 11:17 AM UTC